SCHEMBL650495

SCHEMBL650495

CCCCn1c(-c2ccccc2C)nc(Cl)c1CN(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
F2R P25116 2/20 0.44
HSP90AA1 P07900 2/20 0.41
HSP90AB1 P08238 2/20 0.41
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 1/20 0.39
GFER P55789 1/20 0.39
TSHR P16473 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
USP2 O75604 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RAB9A P51151 1/20 0.38
HIF1A Q16665 1/20 0.38
PKM P14618 2/20 0.37
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650047 0.90 C5AR1 (0.44) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL654075 0.89 C5AR1 (0.49) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL649661 0.89 C5AR1 (0.66) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL648388 0.88 C5AR1 (0.64) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL648683 0.88 C5AR1 (0.42) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL1913104 0.87 C5AR1 (0.42) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL1913100 0.87 C5AR1 (0.42) C5AR1LMNAALDH1A1TSHRKMT2A
SCHEMBL1912840 0.86 C5AR1 (0.63) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL652326 0.86 C5AR1 (0.40) C5AR1SMN1; SMN2LMNAL3MBTL1F2R
SCHEMBL648590 0.86 C5AR1 (0.40) C5AR1SMN1; SMN2LMNAL3MBTL1F2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed